nodes	percent_of_prediction	percent_of_DWPC	metapath
Naratriptan—HTR1D—meninx—malignant glioma	0.102	0.196	CbGeAlD
Naratriptan—HTR1B—dura mater—malignant glioma	0.0966	0.187	CbGeAlD
Naratriptan—HTR1D—dura mater—malignant glioma	0.0935	0.181	CbGeAlD
Naratriptan—HTR1B—telencephalic ventricle—malignant glioma	0.0241	0.0465	CbGeAlD
Naratriptan—HTR1D—telencephalic ventricle—malignant glioma	0.0233	0.045	CbGeAlD
Naratriptan—HTR1A—telencephalic ventricle—malignant glioma	0.0194	0.0375	CbGeAlD
Naratriptan—Cerebral infarction—Carmustine—malignant glioma	0.0149	0.0414	CcSEcCtD
Naratriptan—Vasospasm—Carmustine—malignant glioma	0.0142	0.0395	CcSEcCtD
Naratriptan—HTR1F—telencephalon—malignant glioma	0.0141	0.0273	CbGeAlD
Naratriptan—HTR1B—blood vessel—malignant glioma	0.0119	0.023	CbGeAlD
Naratriptan—HTR1D—blood vessel—malignant glioma	0.0115	0.0223	CbGeAlD
Naratriptan—Altered state of consciousness—Temozolomide—malignant glioma	0.0102	0.0282	CcSEcCtD
Naratriptan—Transient ischaemic attack—Temozolomide—malignant glioma	0.00929	0.0258	CcSEcCtD
Naratriptan—HTR1F—central nervous system—malignant glioma	0.00802	0.0155	CbGeAlD
Naratriptan—Haemorrhoids—Temozolomide—malignant glioma	0.00797	0.0222	CcSEcCtD
Naratriptan—Aphasia—Carmustine—malignant glioma	0.00748	0.0208	CcSEcCtD
Naratriptan—Aphasia—Temozolomide—malignant glioma	0.00723	0.0201	CcSEcCtD
Naratriptan—Burning sensation—Carmustine—malignant glioma	0.00698	0.0194	CcSEcCtD
Naratriptan—HTR1B—brainstem—malignant glioma	0.00651	0.0126	CbGeAlD
Naratriptan—Scotoma—Carmustine—malignant glioma	0.00639	0.0178	CcSEcCtD
Naratriptan—HTR1F—brain—malignant glioma	0.00636	0.0123	CbGeAlD
Naratriptan—HTR1D—brainstem—malignant glioma	0.0063	0.0122	CbGeAlD
Naratriptan—Scotoma—Temozolomide—malignant glioma	0.00617	0.0172	CcSEcCtD
Naratriptan—Hyperaesthesia—Temozolomide—malignant glioma	0.00597	0.0166	CcSEcCtD
Naratriptan—HTR1B—telencephalon—malignant glioma	0.00578	0.0112	CbGeAlD
Naratriptan—HTR1D—telencephalon—malignant glioma	0.00559	0.0108	CbGeAlD
Naratriptan—HTR1A—brainstem—malignant glioma	0.00525	0.0102	CbGeAlD
Naratriptan—MAOA—embryo—malignant glioma	0.00524	0.0101	CbGeAlD
Naratriptan—Coordination abnormal—Carmustine—malignant glioma	0.00494	0.0137	CcSEcCtD
Naratriptan—MAOA—brainstem—malignant glioma	0.0048	0.00928	CbGeAlD
Naratriptan—Coordination abnormal—Temozolomide—malignant glioma	0.00477	0.0133	CcSEcCtD
Naratriptan—Vaginal inflammation—Temozolomide—malignant glioma	0.00469	0.013	CcSEcCtD
Naratriptan—Urinary incontinence—Carmustine—malignant glioma	0.00468	0.013	CcSEcCtD
Naratriptan—Depressed level of consciousness—Carmustine—malignant glioma	0.00468	0.013	CcSEcCtD
Naratriptan—HTR1A—telencephalon—malignant glioma	0.00466	0.00901	CbGeAlD
Naratriptan—MAOA—retina—malignant glioma	0.00463	0.00895	CbGeAlD
Naratriptan—Depressed level of consciousness—Temozolomide—malignant glioma	0.00453	0.0126	CcSEcCtD
Naratriptan—Urinary incontinence—Temozolomide—malignant glioma	0.00453	0.0126	CcSEcCtD
Naratriptan—Vaginal infection—Temozolomide—malignant glioma	0.00443	0.0123	CcSEcCtD
Naratriptan—Dry eye—Temozolomide—malignant glioma	0.00433	0.012	CcSEcCtD
Naratriptan—MAOA—telencephalon—malignant glioma	0.00426	0.00823	CbGeAlD
Naratriptan—HTR1B—midbrain—malignant glioma	0.00415	0.00802	CbGeAlD
Naratriptan—HTR1B—spinal cord—malignant glioma	0.00405	0.00783	CbGeAlD
Naratriptan—HTR1D—midbrain—malignant glioma	0.00402	0.00777	CbGeAlD
Naratriptan—Swelling—Carmustine—malignant glioma	0.00399	0.0111	CcSEcCtD
Naratriptan—Eye pain—Carmustine—malignant glioma	0.0039	0.0108	CcSEcCtD
Naratriptan—Gastroenteritis—Temozolomide—malignant glioma	0.00384	0.0107	CcSEcCtD
Naratriptan—Vascular purpura—Temozolomide—malignant glioma	0.0038	0.0106	CcSEcCtD
Naratriptan—Eye pain—Temozolomide—malignant glioma	0.00377	0.0105	CcSEcCtD
Naratriptan—Thirst—Temozolomide—malignant glioma	0.00358	0.00994	CcSEcCtD
Naratriptan—Purpura—Temozolomide—malignant glioma	0.00353	0.00982	CcSEcCtD
Naratriptan—HTR1A—midbrain—malignant glioma	0.00335	0.00647	CbGeAlD
Naratriptan—MAOA—medulla oblongata—malignant glioma	0.00335	0.00647	CbGeAlD
Naratriptan—HTR1B—central nervous system—malignant glioma	0.00328	0.00635	CbGeAlD
Naratriptan—HTR1A—spinal cord—malignant glioma	0.00327	0.00631	CbGeAlD
Naratriptan—Liver function test abnormal—Carmustine—malignant glioma	0.00325	0.00904	CcSEcCtD
Naratriptan—HTR1D—central nervous system—malignant glioma	0.00318	0.00615	CbGeAlD
Naratriptan—Dehydration—Temozolomide—malignant glioma	0.00316	0.0088	CcSEcCtD
Naratriptan—Dry skin—Temozolomide—malignant glioma	0.00312	0.00867	CcSEcCtD
Naratriptan—MAOA—midbrain—malignant glioma	0.00306	0.00591	CbGeAlD
Naratriptan—MAOA—spinal cord—malignant glioma	0.00298	0.00577	CbGeAlD
Naratriptan—Bronchitis—Temozolomide—malignant glioma	0.00283	0.00787	CcSEcCtD
Naratriptan—Hyperglycaemia—Carmustine—malignant glioma	0.00275	0.00763	CcSEcCtD
Naratriptan—Pneumonia—Carmustine—malignant glioma	0.00273	0.00759	CcSEcCtD
Naratriptan—Pollakiuria—Temozolomide—malignant glioma	0.00272	0.00756	CcSEcCtD
Naratriptan—Depression—Carmustine—malignant glioma	0.00271	0.00752	CcSEcCtD
Naratriptan—Photosensitivity reaction—Temozolomide—malignant glioma	0.00268	0.00747	CcSEcCtD
Naratriptan—Neuropathy peripheral—Carmustine—malignant glioma	0.00266	0.0074	CcSEcCtD
Naratriptan—Hyperglycaemia—Temozolomide—malignant glioma	0.00265	0.00738	CcSEcCtD
Naratriptan—HTR1A—central nervous system—malignant glioma	0.00265	0.00512	CbGeAlD
Naratriptan—Pneumonia—Temozolomide—malignant glioma	0.00264	0.00734	CcSEcCtD
Naratriptan—Depression—Temozolomide—malignant glioma	0.00261	0.00727	CcSEcCtD
Naratriptan—HTR1B—brain—malignant glioma	0.00261	0.00504	CbGeAlD
Naratriptan—HTR1A—cerebellum—malignant glioma	0.00259	0.00501	CbGeAlD
Naratriptan—Neuropathy peripheral—Temozolomide—malignant glioma	0.00257	0.00715	CcSEcCtD
Naratriptan—HTR1D—brain—malignant glioma	0.00252	0.00488	CbGeAlD
Naratriptan—Sinusitis—Temozolomide—malignant glioma	0.00246	0.00684	CcSEcCtD
Naratriptan—Haemoglobin—Carmustine—malignant glioma	0.00245	0.00681	CcSEcCtD
Naratriptan—Haemorrhage—Carmustine—malignant glioma	0.00244	0.00677	CcSEcCtD
Naratriptan—Hallucination—Carmustine—malignant glioma	0.00242	0.00674	CcSEcCtD
Naratriptan—Hypoaesthesia—Carmustine—malignant glioma	0.00242	0.00674	CcSEcCtD
Naratriptan—MAOA—central nervous system—malignant glioma	0.00242	0.00468	CbGeAlD
Naratriptan—MAOA—cerebellum—malignant glioma	0.00237	0.00457	CbGeAlD
Naratriptan—Haemoglobin—Temozolomide—malignant glioma	0.00237	0.00658	CcSEcCtD
Naratriptan—Haemorrhage—Temozolomide—malignant glioma	0.00235	0.00655	CcSEcCtD
Naratriptan—Hallucination—Temozolomide—malignant glioma	0.00234	0.00651	CcSEcCtD
Naratriptan—Hypoaesthesia—Temozolomide—malignant glioma	0.00234	0.00651	CcSEcCtD
Naratriptan—Tinnitus—Temozolomide—malignant glioma	0.0022	0.0061	CcSEcCtD
Naratriptan—Cardiac disorder—Temozolomide—malignant glioma	0.00218	0.00608	CcSEcCtD
Naratriptan—Arrhythmia—Carmustine—malignant glioma	0.00218	0.00605	CcSEcCtD
Naratriptan—Alopecia—Carmustine—malignant glioma	0.00215	0.00599	CcSEcCtD
Naratriptan—Angiopathy—Temozolomide—malignant glioma	0.00214	0.00594	CcSEcCtD
Naratriptan—Immune system disorder—Temozolomide—malignant glioma	0.00213	0.00591	CcSEcCtD
Naratriptan—Erythema—Carmustine—malignant glioma	0.00212	0.0059	CcSEcCtD
Naratriptan—Chills—Temozolomide—malignant glioma	0.00211	0.00587	CcSEcCtD
Naratriptan—HTR1A—brain—malignant glioma	0.0021	0.00407	CbGeAlD
Naratriptan—Alopecia—Temozolomide—malignant glioma	0.00208	0.00579	CcSEcCtD
Naratriptan—Erythema—Temozolomide—malignant glioma	0.00205	0.0057	CcSEcCtD
Naratriptan—Vision blurred—Carmustine—malignant glioma	0.002	0.00556	CcSEcCtD
Naratriptan—Tremor—Carmustine—malignant glioma	0.00199	0.00553	CcSEcCtD
Naratriptan—Anaemia—Carmustine—malignant glioma	0.00196	0.00545	CcSEcCtD
Naratriptan—Agitation—Carmustine—malignant glioma	0.00195	0.00542	CcSEcCtD
Naratriptan—Vision blurred—Temozolomide—malignant glioma	0.00193	0.00537	CcSEcCtD
Naratriptan—MAOA—brain—malignant glioma	0.00192	0.00372	CbGeAlD
Naratriptan—Tremor—Temozolomide—malignant glioma	0.00192	0.00534	CcSEcCtD
Naratriptan—Ill-defined disorder—Temozolomide—malignant glioma	0.0019	0.00529	CcSEcCtD
Naratriptan—Anaemia—Temozolomide—malignant glioma	0.00189	0.00527	CcSEcCtD
Naratriptan—Agitation—Temozolomide—malignant glioma	0.00188	0.00524	CcSEcCtD
Naratriptan—Malaise—Temozolomide—malignant glioma	0.00185	0.00514	CcSEcCtD
Naratriptan—Vertigo—Temozolomide—malignant glioma	0.00184	0.00512	CcSEcCtD
Naratriptan—Convulsion—Carmustine—malignant glioma	0.00184	0.00511	CcSEcCtD
Naratriptan—Palpitations—Temozolomide—malignant glioma	0.00181	0.00504	CcSEcCtD
Naratriptan—Myalgia—Carmustine—malignant glioma	0.00181	0.00502	CcSEcCtD
Naratriptan—Anxiety—Carmustine—malignant glioma	0.0018	0.005	CcSEcCtD
Naratriptan—Cough—Temozolomide—malignant glioma	0.00179	0.00497	CcSEcCtD
Naratriptan—Convulsion—Temozolomide—malignant glioma	0.00178	0.00494	CcSEcCtD
Naratriptan—Confusional state—Carmustine—malignant glioma	0.00175	0.00485	CcSEcCtD
Naratriptan—Arthralgia—Temozolomide—malignant glioma	0.00174	0.00485	CcSEcCtD
Naratriptan—Myalgia—Temozolomide—malignant glioma	0.00174	0.00485	CcSEcCtD
Naratriptan—Anxiety—Temozolomide—malignant glioma	0.00174	0.00484	CcSEcCtD
Naratriptan—Oedema—Carmustine—malignant glioma	0.00173	0.00481	CcSEcCtD
Naratriptan—Discomfort—Temozolomide—malignant glioma	0.00172	0.00479	CcSEcCtD
Naratriptan—Infection—Carmustine—malignant glioma	0.00172	0.00478	CcSEcCtD
Naratriptan—Dry mouth—Temozolomide—malignant glioma	0.00171	0.00475	CcSEcCtD
Naratriptan—Thrombocytopenia—Carmustine—malignant glioma	0.00169	0.00471	CcSEcCtD
Naratriptan—Confusional state—Temozolomide—malignant glioma	0.00169	0.00469	CcSEcCtD
Naratriptan—Anaphylactic shock—Temozolomide—malignant glioma	0.00167	0.00465	CcSEcCtD
Naratriptan—Oedema—Temozolomide—malignant glioma	0.00167	0.00465	CcSEcCtD
Naratriptan—Infection—Temozolomide—malignant glioma	0.00166	0.00462	CcSEcCtD
Naratriptan—Nervous system disorder—Temozolomide—malignant glioma	0.00164	0.00456	CcSEcCtD
Naratriptan—Thrombocytopenia—Temozolomide—malignant glioma	0.00164	0.00455	CcSEcCtD
Naratriptan—Skin disorder—Temozolomide—malignant glioma	0.00162	0.00452	CcSEcCtD
Naratriptan—Hypotension—Carmustine—malignant glioma	0.00162	0.0045	CcSEcCtD
Naratriptan—Hyperhidrosis—Temozolomide—malignant glioma	0.00162	0.0045	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00158	0.00438	CcSEcCtD
Naratriptan—Paraesthesia—Carmustine—malignant glioma	0.00155	0.00432	CcSEcCtD
Naratriptan—Dyspnoea—Carmustine—malignant glioma	0.00154	0.00429	CcSEcCtD
Naratriptan—Somnolence—Carmustine—malignant glioma	0.00154	0.00428	CcSEcCtD
Naratriptan—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00152	0.00424	CcSEcCtD
Naratriptan—Paraesthesia—Temozolomide—malignant glioma	0.0015	0.00418	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Carmustine—malignant glioma	0.00149	0.00416	CcSEcCtD
Naratriptan—Dyspnoea—Temozolomide—malignant glioma	0.00149	0.00415	CcSEcCtD
Naratriptan—Somnolence—Temozolomide—malignant glioma	0.00149	0.00413	CcSEcCtD
Naratriptan—Pain—Carmustine—malignant glioma	0.00148	0.00412	CcSEcCtD
Naratriptan—Constipation—Carmustine—malignant glioma	0.00148	0.00412	CcSEcCtD
Naratriptan—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00144	0.00402	CcSEcCtD
Naratriptan—Fatigue—Temozolomide—malignant glioma	0.00144	0.00401	CcSEcCtD
Naratriptan—Pain—Temozolomide—malignant glioma	0.00143	0.00398	CcSEcCtD
Naratriptan—Constipation—Temozolomide—malignant glioma	0.00143	0.00398	CcSEcCtD
Naratriptan—Feeling abnormal—Carmustine—malignant glioma	0.00143	0.00397	CcSEcCtD
Naratriptan—Feeling abnormal—Temozolomide—malignant glioma	0.00138	0.00383	CcSEcCtD
Naratriptan—Body temperature increased—Carmustine—malignant glioma	0.00137	0.0038	CcSEcCtD
Naratriptan—Urticaria—Temozolomide—malignant glioma	0.00133	0.00369	CcSEcCtD
Naratriptan—Body temperature increased—Temozolomide—malignant glioma	0.00132	0.00368	CcSEcCtD
Naratriptan—Hypersensitivity—Carmustine—malignant glioma	0.00128	0.00355	CcSEcCtD
Naratriptan—Asthenia—Carmustine—malignant glioma	0.00124	0.00345	CcSEcCtD
Naratriptan—Hypersensitivity—Temozolomide—malignant glioma	0.00123	0.00343	CcSEcCtD
Naratriptan—Asthenia—Temozolomide—malignant glioma	0.0012	0.00334	CcSEcCtD
Naratriptan—Diarrhoea—Carmustine—malignant glioma	0.00118	0.00329	CcSEcCtD
Naratriptan—Pruritus—Temozolomide—malignant glioma	0.00118	0.00329	CcSEcCtD
Naratriptan—Dizziness—Carmustine—malignant glioma	0.00114	0.00318	CcSEcCtD
Naratriptan—Diarrhoea—Temozolomide—malignant glioma	0.00114	0.00318	CcSEcCtD
Naratriptan—Dizziness—Temozolomide—malignant glioma	0.00111	0.00308	CcSEcCtD
Naratriptan—Vomiting—Carmustine—malignant glioma	0.0011	0.00306	CcSEcCtD
Naratriptan—Rash—Carmustine—malignant glioma	0.00109	0.00303	CcSEcCtD
Naratriptan—Dermatitis—Carmustine—malignant glioma	0.00109	0.00303	CcSEcCtD
Naratriptan—Headache—Carmustine—malignant glioma	0.00108	0.00302	CcSEcCtD
Naratriptan—Vomiting—Temozolomide—malignant glioma	0.00106	0.00296	CcSEcCtD
Naratriptan—Rash—Temozolomide—malignant glioma	0.00105	0.00293	CcSEcCtD
Naratriptan—Dermatitis—Temozolomide—malignant glioma	0.00105	0.00293	CcSEcCtD
Naratriptan—Headache—Temozolomide—malignant glioma	0.00105	0.00291	CcSEcCtD
Naratriptan—Nausea—Carmustine—malignant glioma	0.00103	0.00286	CcSEcCtD
Naratriptan—Nausea—Temozolomide—malignant glioma	0.000993	0.00276	CcSEcCtD
Naratriptan—Eletriptan—PTGS1—malignant glioma	0.0009	1	CrCbGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CD—malignant glioma	7.16e-05	0.000586	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—F2—malignant glioma	7.14e-05	0.000584	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FN1—malignant glioma	7.14e-05	0.000584	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PTPN11—malignant glioma	7.11e-05	0.000582	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH2—malignant glioma	7.07e-05	0.000578	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KNG1—malignant glioma	7.06e-05	0.000578	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—BAD—malignant glioma	7.05e-05	0.000577	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CD—malignant glioma	7.01e-05	0.000574	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—NOTCH1—malignant glioma	6.98e-05	0.000572	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KNG1—malignant glioma	6.91e-05	0.000566	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CD80—malignant glioma	6.84e-05	0.00056	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—APC—malignant glioma	6.83e-05	0.000559	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CG—malignant glioma	6.83e-05	0.000559	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT2—malignant glioma	6.76e-05	0.000554	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGF—malignant glioma	6.75e-05	0.000553	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NTRK1—malignant glioma	6.73e-05	0.000551	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—GSTP1—malignant glioma	6.72e-05	0.00055	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTPN11—malignant glioma	6.71e-05	0.000549	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT2—malignant glioma	6.62e-05	0.000542	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NTRK1—malignant glioma	6.59e-05	0.000539	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAT—malignant glioma	6.54e-05	0.000535	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CD—malignant glioma	6.5e-05	0.000532	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—BRAF—malignant glioma	6.42e-05	0.000525	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—H3F3A—malignant glioma	6.39e-05	0.000523	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CD—malignant glioma	6.36e-05	0.000521	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—F2—malignant glioma	6.35e-05	0.000519	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCR3—malignant glioma	6.33e-05	0.000518	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP3—malignant glioma	6.26e-05	0.000512	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT2—malignant glioma	6.25e-05	0.000511	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CB—malignant glioma	6.24e-05	0.000511	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—EGFR—malignant glioma	6.22e-05	0.000509	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CDKN2B—malignant glioma	6.2e-05	0.000508	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—NCOR1—malignant glioma	6.17e-05	0.000505	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—YWHAE—malignant glioma	6.16e-05	0.000504	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK2—malignant glioma	6.16e-05	0.000504	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FLT1—malignant glioma	6.13e-05	0.000502	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP3—malignant glioma	6.13e-05	0.000501	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CB—malignant glioma	6.11e-05	0.0005	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—DUSP6—malignant glioma	6.1e-05	0.0005	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CG—malignant glioma	6.07e-05	0.000497	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CDKN2B—malignant glioma	6.07e-05	0.000497	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—JAG1—malignant glioma	6.03e-05	0.000493	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTK2—malignant glioma	6.02e-05	0.000493	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CD—malignant glioma	6e-05	0.000491	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH3—malignant glioma	6e-05	0.000491	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—CXCL8—malignant glioma	6e-05	0.000491	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—PIK3CA—malignant glioma	5.95e-05	0.000487	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HES1—malignant glioma	5.92e-05	0.000484	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FBXW7—malignant glioma	5.9e-05	0.000483	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTK2—malignant glioma	5.9e-05	0.000483	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NCOR1—malignant glioma	5.88e-05	0.000481	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—KRAS—malignant glioma	5.88e-05	0.000481	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—CXCL8—malignant glioma	5.87e-05	0.00048	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—RAF1—malignant glioma	5.8e-05	0.000475	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HES1—malignant glioma	5.79e-05	0.000474	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BDKRB2—malignant glioma	5.79e-05	0.000474	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—F2—malignant glioma	5.76e-05	0.000472	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NCOR1—malignant glioma	5.76e-05	0.000471	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—FGF2—malignant glioma	5.75e-05	0.000471	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—IL2—malignant glioma	5.73e-05	0.000469	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—RAF1—malignant glioma	5.68e-05	0.000465	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CB—malignant glioma	5.67e-05	0.000464	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDGFRA—malignant glioma	5.63e-05	0.000461	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—IL2—malignant glioma	5.61e-05	0.000459	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT2—malignant glioma	5.56e-05	0.000455	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CB—malignant glioma	5.55e-05	0.000454	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDGFRA—malignant glioma	5.52e-05	0.000451	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CG—malignant glioma	5.52e-05	0.000451	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—SPP1—malignant glioma	5.47e-05	0.000448	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—CXCL8—malignant glioma	5.44e-05	0.000446	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PTPN11—malignant glioma	5.42e-05	0.000443	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—PIK3CA—malignant glioma	5.4e-05	0.000442	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH2—malignant glioma	5.38e-05	0.000441	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MDM2—malignant glioma	5.38e-05	0.00044	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—RAF1—malignant glioma	5.36e-05	0.000439	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—SPP1—malignant glioma	5.35e-05	0.000438	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CD—malignant glioma	5.34e-05	0.000437	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—CXCL8—malignant glioma	5.33e-05	0.000436	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—ERBB2—malignant glioma	5.3e-05	0.000434	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KNG1—malignant glioma	5.27e-05	0.000431	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CB—malignant glioma	5.23e-05	0.000428	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—IL2—malignant glioma	5.2e-05	0.000426	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TERT—malignant glioma	5.18e-05	0.000424	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—IL2—malignant glioma	5.09e-05	0.000417	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TERT—malignant glioma	5.08e-05	0.000415	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PDGFB—malignant glioma	5.06e-05	0.000414	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT2—malignant glioma	5.05e-05	0.000413	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGFR1—malignant glioma	5.03e-05	0.000412	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—CAV1—malignant glioma	5.03e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CXCL8—malignant glioma	5.03e-05	0.000412	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NTRK1—malignant glioma	5.02e-05	0.000411	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—HIF1A—malignant glioma	4.96e-05	0.000406	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PDGFB—malignant glioma	4.95e-05	0.000405	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGFR1—malignant glioma	4.93e-05	0.000403	CbGpPWpGaD
Naratriptan—HTR1F—GPCR downstream signaling—AKT1—malignant glioma	4.86e-05	0.000398	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—HIF1A—malignant glioma	4.85e-05	0.000397	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CD—malignant glioma	4.85e-05	0.000397	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—CASP3—malignant glioma	4.81e-05	0.000394	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—IL2—malignant glioma	4.81e-05	0.000393	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CAV1—malignant glioma	4.8e-05	0.000392	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KDR—malignant glioma	4.74e-05	0.000388	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CAV1—malignant glioma	4.7e-05	0.000384	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP3—malignant glioma	4.67e-05	0.000382	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CB—malignant glioma	4.65e-05	0.000381	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KDR—malignant glioma	4.64e-05	0.00038	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CDKN2B—malignant glioma	4.63e-05	0.000379	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CG—malignant glioma	4.58e-05	0.000375	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—F2—malignant glioma	4.56e-05	0.000374	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FN1—malignant glioma	4.56e-05	0.000374	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MMP9—malignant glioma	4.55e-05	0.000372	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PTEN—malignant glioma	4.52e-05	0.00037	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BAD—malignant glioma	4.51e-05	0.000369	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTK2—malignant glioma	4.49e-05	0.000368	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—CXCL8—malignant glioma	4.47e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—F2—malignant glioma	4.47e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FN1—malignant glioma	4.47e-05	0.000366	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—NOTCH1—malignant glioma	4.47e-05	0.000366	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PPARG—malignant glioma	4.42e-05	0.000362	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BAD—malignant glioma	4.42e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HES1—malignant glioma	4.41e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1F—Signaling by GPCR—AKT1—malignant glioma	4.41e-05	0.000361	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NCOR1—malignant glioma	4.39e-05	0.000359	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CD80—malignant glioma	4.38e-05	0.000358	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—NOTCH1—malignant glioma	4.37e-05	0.000358	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—APC—malignant glioma	4.37e-05	0.000357	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CG—malignant glioma	4.37e-05	0.000357	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—RAF1—malignant glioma	4.33e-05	0.000354	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGF—malignant glioma	4.32e-05	0.000353	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTPN11—malignant glioma	4.29e-05	0.000351	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CD80—malignant glioma	4.28e-05	0.000351	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—APC—malignant glioma	4.28e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CG—malignant glioma	4.28e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—IL2—malignant glioma	4.27e-05	0.00035	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGF—malignant glioma	4.23e-05	0.000346	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CB—malignant glioma	4.23e-05	0.000346	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDGFRA—malignant glioma	4.2e-05	0.000344	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTPN11—malignant glioma	4.2e-05	0.000344	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—BRAF—malignant glioma	4.11e-05	0.000336	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—VEGFA—malignant glioma	4.08e-05	0.000334	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—SPP1—malignant glioma	4.08e-05	0.000334	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—CXCL8—malignant glioma	4.06e-05	0.000332	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—STAT3—malignant glioma	4.04e-05	0.000331	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CD—malignant glioma	4.03e-05	0.00033	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—BRAF—malignant glioma	4.02e-05	0.000329	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT2—malignant glioma	4e-05	0.000327	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—EGFR—malignant glioma	3.98e-05	0.000326	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT2—malignant glioma	3.91e-05	0.00032	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—EGFR—malignant glioma	3.9e-05	0.000319	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—IL2—malignant glioma	3.88e-05	0.000318	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TERT—malignant glioma	3.87e-05	0.000316	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CD—malignant glioma	3.84e-05	0.000314	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—PIK3CA—malignant glioma	3.8e-05	0.000311	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PDGFB—malignant glioma	3.77e-05	0.000309	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CD—malignant glioma	3.76e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—KRAS—malignant glioma	3.76e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—MYC—malignant glioma	3.76e-05	0.000308	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGFR1—malignant glioma	3.75e-05	0.000307	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—PIK3CA—malignant glioma	3.72e-05	0.000305	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—HIF1A—malignant glioma	3.7e-05	0.000303	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—KRAS—malignant glioma	3.68e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—FGF2—malignant glioma	3.68e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—EGFR—malignant glioma	3.68e-05	0.000301	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—FGF2—malignant glioma	3.6e-05	0.000295	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CAV1—malignant glioma	3.58e-05	0.000293	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KDR—malignant glioma	3.54e-05	0.000289	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CB—malignant glioma	3.51e-05	0.000287	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTGS2—malignant glioma	3.48e-05	0.000285	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—KRAS—malignant glioma	3.47e-05	0.000284	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—PIK3CA—malignant glioma	3.45e-05	0.000283	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MDM2—malignant glioma	3.44e-05	0.000282	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—RAF1—malignant glioma	3.43e-05	0.000281	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FN1—malignant glioma	3.4e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—F2—malignant glioma	3.4e-05	0.000279	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—ERBB2—malignant glioma	3.39e-05	0.000278	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—PIK3CA—malignant glioma	3.38e-05	0.000277	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MDM2—malignant glioma	3.37e-05	0.000276	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BAD—malignant glioma	3.36e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—RAF1—malignant glioma	3.36e-05	0.000275	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CB—malignant glioma	3.35e-05	0.000274	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—NOTCH1—malignant glioma	3.33e-05	0.000273	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—ERBB2—malignant glioma	3.32e-05	0.000272	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CB—malignant glioma	3.28e-05	0.000268	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CD80—malignant glioma	3.26e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CG—malignant glioma	3.26e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—APC—malignant glioma	3.26e-05	0.000267	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGF—malignant glioma	3.22e-05	0.000264	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CXCL8—malignant glioma	3.22e-05	0.000263	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTPN11—malignant glioma	3.2e-05	0.000262	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—PIK3CA—malignant glioma	3.19e-05	0.000261	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CXCL8—malignant glioma	3.15e-05	0.000258	CbGpPWpGaD
Naratriptan—HTR1D—GPCR downstream signaling—AKT1—malignant glioma	3.11e-05	0.000254	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—TP53—malignant glioma	3.09e-05	0.000253	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—CASP3—malignant glioma	3.08e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—IL2—malignant glioma	3.07e-05	0.000252	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—BRAF—malignant glioma	3.06e-05	0.000251	CbGpPWpGaD
Naratriptan—HTR1B—GPCR downstream signaling—AKT1—malignant glioma	3.04e-05	0.000249	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PTEN—malignant glioma	3.03e-05	0.000248	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—CASP3—malignant glioma	3.01e-05	0.000247	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—IL2—malignant glioma	3.01e-05	0.000246	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT2—malignant glioma	2.98e-05	0.000244	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—EGFR—malignant glioma	2.97e-05	0.000243	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MMP9—malignant glioma	2.91e-05	0.000238	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PTEN—malignant glioma	2.89e-05	0.000237	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CD—malignant glioma	2.86e-05	0.000234	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MMP9—malignant glioma	2.85e-05	0.000233	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.84e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PTEN—malignant glioma	2.83e-05	0.000232	CbGpPWpGaD
Naratriptan—HTR1D—Signaling by GPCR—AKT1—malignant glioma	2.82e-05	0.000231	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—KRAS—malignant glioma	2.8e-05	0.000229	CbGpPWpGaD
Naratriptan—HTR1B—Signaling by GPCR—AKT1—malignant glioma	2.76e-05	0.000226	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—FGF2—malignant glioma	2.74e-05	0.000224	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—VEGFA—malignant glioma	2.61e-05	0.000214	CbGpPWpGaD
Naratriptan—HTR1F—Signaling Pathways—AKT1—malignant glioma	2.61e-05	0.000213	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—STAT3—malignant glioma	2.59e-05	0.000212	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	2.58e-05	0.000211	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MDM2—malignant glioma	2.57e-05	0.00021	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—VEGFA—malignant glioma	2.56e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—RAF1—malignant glioma	2.56e-05	0.000209	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—STAT3—malignant glioma	2.53e-05	0.000207	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—ERBB2—malignant glioma	2.53e-05	0.000207	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	2.5e-05	0.000204	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—MYC—malignant glioma	2.4e-05	0.000197	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CXCL8—malignant glioma	2.4e-05	0.000196	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—MYC—malignant glioma	2.35e-05	0.000193	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—EGFR—malignant glioma	2.35e-05	0.000192	CbGpPWpGaD
Naratriptan—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	2.32e-05	0.00019	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—EGFR—malignant glioma	2.3e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—CASP3—malignant glioma	2.3e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—IL2—malignant glioma	2.29e-05	0.000188	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—KRAS—malignant glioma	2.22e-05	0.000182	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—KRAS—malignant glioma	2.17e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MMP9—malignant glioma	2.17e-05	0.000178	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PTEN—malignant glioma	2.16e-05	0.000177	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—PIK3CA—malignant glioma	2.14e-05	0.000175	CbGpPWpGaD
Naratriptan—HTR1A—Signaling by GPCR—AKT1—malignant glioma	2.1e-05	0.000172	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—PIK3CA—malignant glioma	2.04e-05	0.000167	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—PIK3CA—malignant glioma	2e-05	0.000163	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—TP53—malignant glioma	1.97e-05	0.000162	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.95e-05	0.000159	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—TP53—malignant glioma	1.93e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.93e-05	0.000158	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—MYC—malignant glioma	1.79e-05	0.000147	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.75e-05	0.000144	CbGpPWpGaD
Naratriptan—MAOA—Metabolism—AKT1—malignant glioma	1.75e-05	0.000143	CbGpPWpGaD
Naratriptan—HTR1D—Signaling Pathways—AKT1—malignant glioma	1.67e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.66e-05	0.000136	CbGpPWpGaD
Naratriptan—HTR1B—Signaling Pathways—AKT1—malignant glioma	1.63e-05	0.000134	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.52e-05	0.000125	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—TP53—malignant glioma	1.47e-05	0.00012	CbGpPWpGaD
Naratriptan—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.24e-05	0.000102	CbGpPWpGaD
